Pharmacogenomic Services for Older Adults: Seven Design Features From 11 Early Studies
This scoping review maps how pharmacogenomic testing has been operationalized in adults aged 65 years and older and gives geriatric pharmacists a design framework, while explicitly declining to compare clinical effectiveness.
📅 Journal publication: Nov 10, 2026·Last updated: Nov 11, 2026
Pharmacogenomics refines drug therapy for older adults through tailored service models.
Older adults face significant polypharmacy and pharmacokinetic changes, making individualized therapy crucial. The review identified 11 pharmacogenomic services with key design elements supporting precision therapeutics in older adults. The study offers a framework using pharmacogenomics within existing medication management to enhance therapeutic decisions in geriatric care. Pharmacogenomic services for older adults can integrate with current practices to refine drug therapy decisions.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Wehbe E, Patel TJ, Hughes S, Mostafa S, Kirkpatrick CM, Stocker SL
Citation:Wehbe E, Patel TJ, Hughes S, et al. Advancing Precision Therapeutics in Older Adults: A Scoping Review of Pharmacogenomic Service Models. Clinical pharmacology and therapeutics. 2026. doi:10.1002/cpt.70547